Skip to main content
Erschienen in: Neurocritical Care 3/2021

21.05.2021 | Original work

Predicting Mechanical Ventilation Using the EGRIS in Guillain–Barré Syndrome in a Latin American Country

verfasst von: Marco Malaga, Aaron Rodriguez-Calienes, Adrian Marquez-Nakamatsu, Katherine Recuay, Luis Merzthal, Diego Bustamante-Paytan, Juan Manuel Sifuentes, Guillermo Castillo-Kohatsu, Carlos Alva-Diaz

Erschienen in: Neurocritical Care | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Up to one fifth of patients with Guillain–Barré syndrome (GBS) require mechanical ventilation (MV). The Erasmus GBS Respiratory Insufficiency Score (EGRIS) is a clinical predictive model developed in Europe to predict MV requirements among patients with GBS. However, there are significant differences between the Latin American and European population, especially in the distribution of GBS subtypes. Therefore, determining if the EGRIS is able to predict MV in a Latin American population is of clinical significance.

Methods

We retrospectively analyzed clinical and laboratory data of 177 patients with GBS in three Peruvian hospitals. We performed a multivariate logistic regression of the factors making up the EGRIS. Finally, we evaluated the EGRIS discrimination through a receiver operating characteristic curve and determined its calibration through a calibration curve and a Hosmer–Lemeshow test, a test used to determine the goodness of fit.

Results

We found that 14.1% of our patients required MV. One predictive factor of a patient’s need for early MV was the number of days between the onset of motor symptoms and hospitalization. The Medical Research Council sum score did not alter the likelihood of early MV. Bulbar weakness increased the likelihood without showing statistical significance. In contrast, facial weakness was a protective factor of it. The EGRIS was significantly higher in patients who required early MV than in those who did not (P = 0.018). It showed an area under the curve (AUC) of 0.63, with an insignificant Hosmer–Lemeshow test result.

Conclusions

Although the EGRIS was higher in patients who required early MV than in those who did not, it only showed a moderate discrimination capacity (AUC = 0.63). Facial weakness, an item of the EGRIS, was not found to be a predictive factor in our population. We suggest assessing whether these findings are due to subtype predominance and whether a modified version of the EGRIS could improve performance.
Literatur
1.
Zurück zum Zitat Landry O. Note sur la paralysie ascendante aigue. Gaz Hebd Med Paris. 1859;6(472–474):486–8. Landry O. Note sur la paralysie ascendante aigue. Gaz Hebd Med Paris. 1859;6(472–474):486–8.
2.
Zurück zum Zitat Guillain G, Barré J-A, Strohl A. Sur un syndrome de radiculonevrite avec hyperalbuminose due liquide cephalo-rachidien sans reaction cellulaire. Remarque sur les caracteres clinique et graphiques des reflezes tendinuex. Bull Soc Med Hop Paris. 1916;40:1462–70. Guillain G, Barré J-A, Strohl A. Sur un syndrome de radiculonevrite avec hyperalbuminose due liquide cephalo-rachidien sans reaction cellulaire. Remarque sur les caracteres clinique et graphiques des reflezes tendinuex. Bull Soc Med Hop Paris. 1916;40:1462–70.
3.
Zurück zum Zitat Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110(2):100–6.CrossRef Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110(2):100–6.CrossRef
4.
Zurück zum Zitat Govoni V, Granieri E. Epidemiology of the Guillain–Barré syndrome. Curr Opin Neurol. 2001;14(5):605–13.CrossRef Govoni V, Granieri E. Epidemiology of the Guillain–Barré syndrome. Curr Opin Neurol. 2001;14(5):605–13.CrossRef
5.
Zurück zum Zitat Hahn AF. The challenge of respiratory dysfunction in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):871–2.CrossRef Hahn AF. The challenge of respiratory dysfunction in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):871–2.CrossRef
6.
Zurück zum Zitat Sharshar T, Chevret S, Bourdain F, Raphael J-C. French cooperative group on plasma exchange in Guillain–Barré syndrome. Early predictors of mechanical ventilation in Guillain–Barre syndrome. Crit Care Med. 2003;31(1):278–83.CrossRef Sharshar T, Chevret S, Bourdain F, Raphael J-C. French cooperative group on plasma exchange in Guillain–Barré syndrome. Early predictors of mechanical ventilation in Guillain–Barre syndrome. Crit Care Med. 2003;31(1):278–83.CrossRef
7.
Zurück zum Zitat Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S. Mortality in mechanically ventilated patients of Guillain Barré syndrome. Ann Indian Acad Neurol. 2011;14(4):262–6.CrossRef Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S. Mortality in mechanically ventilated patients of Guillain Barré syndrome. Ann Indian Acad Neurol. 2011;14(4):262–6.CrossRef
8.
Zurück zum Zitat Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain–Barré syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998;64(1):74–7.CrossRef Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain–Barré syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998;64(1):74–7.CrossRef
9.
Zurück zum Zitat Wijdicks EFM, Henderson RD, McClelland RL. Emergency intubation for respiratory failure in Guillain–Barré syndrome. Arch Neurol. 2003;60(7):947–8.CrossRef Wijdicks EFM, Henderson RD, McClelland RL. Emergency intubation for respiratory failure in Guillain–Barré syndrome. Arch Neurol. 2003;60(7):947–8.CrossRef
10.
Zurück zum Zitat Orlikowski D, Sharshar T, Porcher R, Annane D, Raphael JC, Clair B. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain–Barré syndrome. Intensive Care Med. 2006;32(12):1962–9.CrossRef Orlikowski D, Sharshar T, Porcher R, Annane D, Raphael JC, Clair B. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain–Barré syndrome. Intensive Care Med. 2006;32(12):1962–9.CrossRef
11.
Zurück zum Zitat Hernández-Torruco J, Canul-Reich J, Frausto-Solís J, Méndex-Castillo JJ. Predictores de falla respiratoria y de la necesidad de ventilación mecánica en el síndrome de Guillain–Barré: una revisión de la literatura. Rev Mex Neurocienc. 2013;14(5):272–80. Hernández-Torruco J, Canul-Reich J, Frausto-Solís J, Méndex-Castillo JJ. Predictores de falla respiratoria y de la necesidad de ventilación mecánica en el síndrome de Guillain–Barré: una revisión de la literatura. Rev Mex Neurocienc. 2013;14(5):272–80.
12.
Zurück zum Zitat Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):893–8.CrossRef Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):893–8.CrossRef
13.
Zurück zum Zitat Toamad U, Kongkamol C, Setthawatcharawanich S, Limapichat K, Phabphal K, Sathirapanya P. Clinical presentations as predictors of prolonged mechanical ventilation in Guillain–Barré syndrome in an institution with limited medical resources. Singapore Med J. 2015;56(10):558–61.CrossRef Toamad U, Kongkamol C, Setthawatcharawanich S, Limapichat K, Phabphal K, Sathirapanya P. Clinical presentations as predictors of prolonged mechanical ventilation in Guillain–Barré syndrome in an institution with limited medical resources. Singapore Med J. 2015;56(10):558–61.CrossRef
14.
Zurück zum Zitat Wu X, Li C, Zhang B, Shen D, Li T, Liu K, et al. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain–Barré syndrome. Crit Care. 2015;19(1):310.CrossRef Wu X, Li C, Zhang B, Shen D, Li T, Liu K, et al. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain–Barré syndrome. Crit Care. 2015;19(1):310.CrossRef
15.
Zurück zum Zitat Walgaard C, Lingsma HF, Ruts L, Drenthen J, van Koningsveld R, Garssen MJP, et al. Prediction of respiratory insufficiency in Guillain–Barré syndrome. Ann Neurol. 2010;67(6):781–7.PubMed Walgaard C, Lingsma HF, Ruts L, Drenthen J, van Koningsveld R, Garssen MJP, et al. Prediction of respiratory insufficiency in Guillain–Barré syndrome. Ann Neurol. 2010;67(6):781–7.PubMed
16.
Zurück zum Zitat Zúñiga-González EA, Rodríguez-de la Cruz A, Millán-Padilla J. Subtipos electrofisiológicos del síndrome de Guillain–Barré en adultos mexicanos. Rev Med Inst Mex Seguro Soc. 2007;45(5):463–8.PubMed Zúñiga-González EA, Rodríguez-de la Cruz A, Millán-Padilla J. Subtipos electrofisiológicos del síndrome de Guillain–Barré en adultos mexicanos. Rev Med Inst Mex Seguro Soc. 2007;45(5):463–8.PubMed
17.
Zurück zum Zitat Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013;12(12):1180–8.CrossRef Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013;12(12):1180–8.CrossRef
18.
Zurück zum Zitat Hughes RAC, Cornblath DR. Guillain–Barré syndrome. Lancet. 2005;366(9497):1653–66.CrossRef Hughes RAC, Cornblath DR. Guillain–Barré syndrome. Lancet. 2005;366(9497):1653–66.CrossRef
19.
Zurück zum Zitat van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome. Lancet Neurol. 2008;7(10):939–50.CrossRef van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome. Lancet Neurol. 2008;7(10):939–50.CrossRef
20.
Zurück zum Zitat dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, et al. Zika virus and the Guillain–Barré syndrome—case series from seven countries. N Engl J Med. 2016;375(16):1598–601.CrossRef dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, et al. Zika virus and the Guillain–Barré syndrome—case series from seven countries. N Engl J Med. 2016;375(16):1598–601.CrossRef
21.
Zurück zum Zitat van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.CrossRef van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.CrossRef
22.
Zurück zum Zitat Asbury A, Arnason B, Karp H, McFarlin D. Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol. 1978;3(6):565–6.CrossRef Asbury A, Arnason B, Karp H, McFarlin D. Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol. 1978;3(6):565–6.CrossRef
23.
Zurück zum Zitat Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27(Suppl 1):S21–4.CrossRef Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27(Suppl 1):S21–4.CrossRef
24.
Zurück zum Zitat Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group, et al. Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5):780–8.CrossRef Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group, et al. Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5):780–8.CrossRef
25.
Zurück zum Zitat Alva-Diaz C, Mori N, Pacheco-Barrios K, Velásquez-Rimachi V, Rivera-Torrejon O, Huerta-Rosario CA, et al. Guía de práctica clínica para el diagnóstico y tratamiento del paciente con síndrome de Guillain-Barré. Neurolgía Argentina. 2020;12(1):36–48.CrossRef Alva-Diaz C, Mori N, Pacheco-Barrios K, Velásquez-Rimachi V, Rivera-Torrejon O, Huerta-Rosario CA, et al. Guía de práctica clínica para el diagnóstico y tratamiento del paciente con síndrome de Guillain-Barré. Neurolgía Argentina. 2020;12(1):36–48.CrossRef
26.
Zurück zum Zitat Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, IGOS Consortium, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–77.CrossRef Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, IGOS Consortium, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–77.CrossRef
27.
Zurück zum Zitat Mcgrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain–Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–63.CrossRef Mcgrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain–Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–63.CrossRef
28.
Zurück zum Zitat Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y. Incidence of Guillain–Barré syndrome (GBS) in Latin America and the Caribbean before and during the 2015–2016 Zika virus epidemic: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(8):e0007622.CrossRef Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y. Incidence of Guillain–Barré syndrome (GBS) in Latin America and the Caribbean before and during the 2015–2016 Zika virus epidemic: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(8):e0007622.CrossRef
29.
Zurück zum Zitat Munayco CV, SotoCabezas MG, Reyes MF, Arica Gutiérrez JA, Napanga SO. [Epidemiology of Guillain–Barré syndrome in Peru]. Rev Peru Med Exp Salud Publica. 2019;36(1):10–6 (Spanish).CrossRef Munayco CV, SotoCabezas MG, Reyes MF, Arica Gutiérrez JA, Napanga SO. [Epidemiology of Guillain–Barré syndrome in Peru]. Rev Peru Med Exp Salud Publica. 2019;36(1):10–6 (Spanish).CrossRef
30.
Zurück zum Zitat Ballón-Manrique B, Campos-Ramos N. Características clínicas y paraclínicas del síndrome de Guillain–Barré en el Hospital Regional Lambayeque. Rev Neuropsiquiatr. 2017;80(1):22–6.CrossRef Ballón-Manrique B, Campos-Ramos N. Características clínicas y paraclínicas del síndrome de Guillain–Barré en el Hospital Regional Lambayeque. Rev Neuropsiquiatr. 2017;80(1):22–6.CrossRef
31.
Zurück zum Zitat Castañeda ML, Deza BL. Respuesta clínica al tratamiento con recambio plasmático en pacientes con síndrome de Guillain Barré. Hospital Guillermo Almenara Irigoyen ESSALUD 1995–1998. Rev Neuropsiquiatr. 2000;63(3–4):182–94. Castañeda ML, Deza BL. Respuesta clínica al tratamiento con recambio plasmático en pacientes con síndrome de Guillain Barré. Hospital Guillermo Almenara Irigoyen ESSALUD 1995–1998. Rev Neuropsiquiatr. 2000;63(3–4):182–94.
32.
Zurück zum Zitat Vásquez C, César J. Costos de tratamiento de pacientes con síndrome Guillain Barré en el servicio de neurología y unidad de cuidados intensivos del Hospital Nacional Edgardo Rebagliati Martins. Trujillo, Peru: Universidad Nacional de Trujillo; 2009. Vásquez C, César J. Costos de tratamiento de pacientes con síndrome Guillain Barré en el servicio de neurología y unidad de cuidados intensivos del Hospital Nacional Edgardo Rebagliati Martins. Trujillo, Peru: Universidad Nacional de Trujillo; 2009.
33.
Zurück zum Zitat Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain–Barré syndrome: a prospective study. Lancet Neurol. 2006;5(12):1021–8.CrossRef Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain–Barré syndrome: a prospective study. Lancet Neurol. 2006;5(12):1021–8.CrossRef
34.
Zurück zum Zitat Yamagishi Y, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, et al. Markers for Guillain–Barré syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst. 2017;22(4):433–9.CrossRef Yamagishi Y, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, et al. Markers for Guillain–Barré syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst. 2017;22(4):433–9.CrossRef
35.
Zurück zum Zitat Tan C-Y, Razali SNO, Goh K-J, Shahrizaila N. The utility of Guillain–Barré syndrome prognostic models in Malaysian patients. J Peripher Nerv Syst. 2019;24(2):168–73.CrossRef Tan C-Y, Razali SNO, Goh K-J, Shahrizaila N. The utility of Guillain–Barré syndrome prognostic models in Malaysian patients. J Peripher Nerv Syst. 2019;24(2):168–73.CrossRef
36.
Zurück zum Zitat Chung HK. Comparison between EGRIS and outcome of Guillain–Barré syndrome: retrospective study in one center [abstract]. Neurology. 2012;78(Suppl 1):P06.144. Chung HK. Comparison between EGRIS and outcome of Guillain–Barré syndrome: retrospective study in one center [abstract]. Neurology. 2012;78(Suppl 1):P06.144.
37.
Zurück zum Zitat Dourado ME, Félix RH, da Silva WKA, Queiroz JW, Jeronimo SMB. Clinical characteristics of Guillain–Barré syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand. 2012;125(1):47–53.CrossRef Dourado ME, Félix RH, da Silva WKA, Queiroz JW, Jeronimo SMB. Clinical characteristics of Guillain–Barré syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand. 2012;125(1):47–53.CrossRef
38.
Zurück zum Zitat Tatsumoto M, Misawa S, Kokubun N, Sekiguchi Y, Hirata K, Kuwabara S, et al. Delayed facial weakness in Guillain–Barré and Miller Fisher syndromes. Muscle Nerve. 2015;51(6):811–4.CrossRef Tatsumoto M, Misawa S, Kokubun N, Sekiguchi Y, Hirata K, Kuwabara S, et al. Delayed facial weakness in Guillain–Barré and Miller Fisher syndromes. Muscle Nerve. 2015;51(6):811–4.CrossRef
39.
Zurück zum Zitat Sekiguchi Y, Misawa S, Suichi T, Amiono H, Shibuya K, Kuwabara S. Facial nerve palsy and disease severity in Guillain–Barre syndrome. J Neurol Sci. 2017;381(Suppl):1073.CrossRef Sekiguchi Y, Misawa S, Suichi T, Amiono H, Shibuya K, Kuwabara S. Facial nerve palsy and disease severity in Guillain–Barre syndrome. J Neurol Sci. 2017;381(Suppl):1073.CrossRef
Metadaten
Titel
Predicting Mechanical Ventilation Using the EGRIS in Guillain–Barré Syndrome in a Latin American Country
verfasst von
Marco Malaga
Aaron Rodriguez-Calienes
Adrian Marquez-Nakamatsu
Katherine Recuay
Luis Merzthal
Diego Bustamante-Paytan
Juan Manuel Sifuentes
Guillermo Castillo-Kohatsu
Carlos Alva-Diaz
Publikationsdatum
21.05.2021
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 3/2021
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-021-01218-z

Weitere Artikel der Ausgabe 3/2021

Neurocritical Care 3/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.